|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Taxes receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total property and equipment, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total other long-term assets | ||||||||||||||||||||
| Right of use operating lease assets | ||||||||||||||||||||
| Total right of use operating lease assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued payroll and benefits | ||||||||||||||||||||
| Total accrued payroll and benefits | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current portion of long-term debt | ||||||||||||||||||||
| Deferred revenue and patient deposits | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||||
| Total current operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Total long-term debt, net | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Total long-term operating lease liabilities | ||||||||||||||||||||
| Revolving credit funds payable | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Common stock, $0.001 par value; shares authorized - 450,000,000; shares issued and outstanding - 71,518,820 and 64,542,461, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...